Solvaypharmaceuticals-us.comProductsGastroenterologyCREON®
This Site All Sites

 


 


 
Creon

 
 

CREON® MINIMICROSPHERES® are indicated for the treatment of pancreatic exocrine insufficiency that is often associated with cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery, and ductal obstruction from neoplasm. 

CREON® MINIMICROSPHERES® are contraindicated in the early stages of acute pancreatitis or in patients who are known to be hypersensitive to pork protein.

Should symptoms of hypersensitivity appear, discontinue medication and initiate symptomatic and supportive therapy if necessary.

The most frequently reported adverse reactions to pancreatic enzyme containing products are gastrointestinal in nature, which may include nausea, vomiting, bloating, cramping, constipation, or diarrhea.  Less frequently, allergic-type reactions have also been observed.  Very high doses of pancreatin have been associated with hyperuricosuria and hyperuricemia.

expand Product Information

expand About Pancreatic Exocrine Insufficiency

expand About Cystic Fibrosis

expand About Chronic Pancreatitis 

expand Solvay Cares

expand Solvay Cares Scholarship Program

CREON® MINIMICROSPHERES® is available by prescription only.  Ask your doctor if CREON® MINIMICROSPHERES® is right for you. 

Click below for prescribing and safety information.

 pdf 

  CREON® MINIMICROSPHERES® 5 Prescribing and Safety Information 
 
CREON® MINIMICROSPHERES® 10 Prescribing and Safety Information
  CREON® MINIMICROSPHERES® 20 Prescribing and Safety Information

 





accueil
© Solvay Pharmaceuticals, Inc. • Important information : Privacy Policy  -  Terms of Use • 
If you have any comments, please contact the webmaster
Date of last update: 6/26/2008